Heldrich Report: The Pharmaceutical/Medical Technology Industry Will Add Almost 15,000 New Jobs
State Needs To Produce More Skilled Graduates Trenton, NJ, November 12, 2002 — New Jersey’s pharmaceutical and medical technology companies are growing and will add almost 15,000 new jobs by the end of this decade, according to a recent report issued by the John J. Heldrich Center for Workforce Development at Rutgers, the State University […]
Government Price Controls on Prescription Drugs May Be More than Patients Bargain For
New Brunswick, NJ, October 7, 2002 — Many critics of the pharmaceutical industry contend that the fastest and easiest way to lower prescription drug costs is for the government to impose price controls. That chorus is gaining momentum in state houses around the nation, as well as in Congress.
Discover Why We Are New Jersey’s ‘Premier’ Industry
New Brunswick, NJ, October 7, 2002 — For years, the telecommunications industry dominated our state’s economy. But over the last decade, the pharmaceutical and medical technology industry has become the key driver of our state’s economic well-being. This is evidenced by the fact that New Jersey is home to more pharmaceutical and medical technology companies […]
Continuing Our Progress Depends on Today’s Health Care Policy Decisions
New Brunswick, NJ, October 7, 2002 — The proliferation of prescription drugs and medical devices has dramatically changed health care over the past quarter century. It also has dramatically changed the HealthCare Institute of New Jersey’s member companies.
Challenges and Opportunities: Pharmaceutical and Medical Technology Industry Trends
New Brunswick, NJ, October 7, 2002 — Decisions made today in New Jersey are shaping the future of human health — both here in the Garden State and around the globe. As a result of the unheralded success in research and innovation, the pharmaceutical and medical technology industry is now poised to conquer some of […]
Who Will Be Our Healers? The Case for Linking Academics and a Job
New Brunswick, NJ, October 7, 2002 — A frequent lament among American employers is the lack of skilled workers to meet the ever-changing needs of the new economy. In fact, survey after survey reports that finding and retaining qualified workers is the number one issue for U.S. industry today.
The High Cost of Low Drug Prices: The Medicare Prescription Drug and Modernization Act
New Brunswick, NJ, October 7, 2002 — The ink is barely dry on the new “Medicare Prescription Drug and Modernization Act” and already opponents of the law are seeking radical changes to it. In addition to the AARP, Families USA, citizen lobbying groups, and members of Congress have recently called for amendments to the new […]
New Jersey’s Pharmaceutical & Medical Technology Industry: The Picture of Health
New Brunswick, NJ, October 7, 2002 — For the seventh consecutive year, New Jersey’s pharmaceutical and medical technology industry emerged as New Jersey’s economic powerhouse and continues to expand. That conclusion was validated by the HealthCare Institute of New Jersey’s annual economic study, “Healthy Opportunities,” which was recently unveiled at an unprecedented meeting with key […]
New Jersey Must Champion Its Life Science Cluster to Remain ‘Medicine Chest of the World’
New Brunswick, NJ, October 7, 2002 — The pharmaceutical and medical technology industry has long been an economic engine in New Jersey, with companies such as Johnson & Johnson and Merck arriving more than a century ago. Now, a groundbreaking study conducted by renowned Harvard Professor Michael E. Porter, underscores the importance of this industry […]
New Jersey Is Still the World’s Cure Corridor
New Brunswick, NJ, October 7, 2002 — A recent article in the Philadelphia Inquirer boldly proclaimed, “Pennsylvania is now the nation’s largest producer of drugs, surpassing New Jersey.” That’s quite a statement. Unfortunately, by most relevant measures, it is more fiction than fact.